TREATMENT RESPONSE WITH ABATACEPT PLUS METHOTREXATE TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK

被引：0
|
作者：
Choy, E. [1 ]
Henning, S. [2 ,3 ]
Brazil, M. [3 ]
Pollock, K. [3 ]
Groves, L. [4 ]
Sugrue, D. [4 ]
Houghton, J. [4 ]
机构：
[1] Cardiff Univ, Cardiff Univ Sch Med, CREATE Ctr, Cardiff, Wales
[2] Nzyme Educ, Portsmouth, England
[3] Bristol Myers Squibb Pharmaceut Ltd, Middlesex, Bristol, England
[4] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2356
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0347
引用
收藏
页码：1299 / 1299
页数：1
相关论文
共 50 条
  • [1] CHANGE IN DISEASE ACTIVITY AND TREATMENT RESPONSE AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS: REAL-WORLD EVIDENCE FROM THE UK
    Henning, S.
    Groves, L.
    Hurst, M.
    Sugrue, D.
    Gordon, J.
    Choy, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1442 - 1443
  • [2] Abatacept Monotherapy Versus Abatacept Plus Methotrexate for Treatment-Refractory Rheumatoid Arthritis
    Pascart, Tristan
    Philippe, Peggy
    Drumez, Elodie
    Deprez, Xavier
    Cortet, Bernard
    Duhamel, Alain
    Houvenagel, Eric
    Flipo, Rene-Marc
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E358 - E363
  • [3] Time to treatment response with abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Kremer, J. M.
    Westhovens, R.
    Le Bars, M.
    Lafosse, C.
    Gaillez, C.
    Koncz, T.
    Schmidely, N.
    Dougados, M.
    Schiff, M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S308 - S308
  • [4] Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
    Blanca Hernández-Cruz
    Uta Kiltz
    Jérôme Avouac
    Tamas Treuer
    Ewa Haladyj
    Jens Gerwien
    Chandreyee Dutta Gupta
    Fabrizio Conti
    Rheumatology and Therapy, 2023, 10 : 1417 - 1457
  • [5] Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
    Hernandez-Cruz, Blanca
    Kiltz, Uta
    Avouac, Jerome
    Treuer, Tamas
    Haladyj, Ewa
    Gerwien, Jens
    Gupta, Chandreyee Dutta
    Conti, Fabrizio
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1417 - 1457
  • [6] Real-world experience with tofacitinib for the treatment of rheumatoid arthritis
    Caporali, Roberto
    Zavaglia, Daniela
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 485 - 495
  • [7] Real world costs and dosing patterns of abatacept and infliximab for the treatment of rheumatoid arthritis
    Trivedi, D. N.
    Kreilick, C.
    Rosenblatt, L. C.
    VALUE IN HEALTH, 2008, 11 (03) : A263 - A263
  • [8] What Is the Treatment Durability and Safety Profile of Rheumatoid Arthritis Patients Treated with Infliximab Plus Methotrexate and/or Leflunomide? an Analysis from a Real-World Registry
    Faraawi, Rafat
    Joshi, Raman
    Bensen, William G.
    Choquette, Denis
    Olsynzynski, Wojciech
    Arendse, Regan
    Sheriff, Maqbool
    Rahman, Proton
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Nantel, Francois
    Lehman, Allen J.
    Otawa, Susan
    Tkaczyk, Cathy
    Osborne, Brendan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] WHAT IS THE TREATMENT DURABILITY AND SAFETY PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB PLUS METHOTREXATE AND/OR LEFLUNOMIDE? AN ANALYSIS FROM A REAL-WORLD REGISTRY
    Faraawi, R.
    Joshi, R.
    Bensen, W.
    Choquette, D.
    Olszynski, W.
    Arendse, R.
    Sheriff, M.
    Rahman, P.
    Sampalis, J.
    Rampakakis, E.
    Tkaczyk, C.
    Nantel, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 714 - 714
  • [10] Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
    Hirose, Wataru
    Harigai, Masayoshi
    Amano, Koichi
    Hidaka, Toshihiko
    Itoh, Kenji
    Aoki, Kazutoshi
    Nakashima, Masahiro
    Nagasawa, Hayato
    Komano, Yukiko
    Nanki, Toshihiro
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 6 (03)
12345